Vaccine race: Russia announces second vaccine registration



[ad_1]

On Wednesday, Putin congratulated researchers at the Siberian Vector Institute, which developed the vaccine. The vaccine was tested in humans in early-phase clinical trials last month. “We need to expand the production of the first and second vaccines,” Putin told state television. “We will continue to work with our foreign partners to promote our vaccine abroad.”

Russia received criticism from experts when it registered the world’s first coronavirus vaccine in mid-August, which has been tested in humans for less than two months. According to the Health Ministry, 400 high-risk patients have received the controversial Sputnik V vaccine so far. Not much used yet.

Since the beginning of the pandemic in Russia approved 1 million. 340 thousand 409 cases of coronavirus. This is the highest number after the United States, India and Brazil.

A coronavirus vaccine is not yet on the market, but it is being developed at full capacity.

No part of this publication may be reproduced without the written permission of ELTA.



[ad_2]